Forcura Signs CSI Pharmacy, Marking Entry Into Home Infusion Market. “Forcura will be crucial to accelerating our conversion to a cloud-based system to improve our visibility of outstanding orders and decrease the turnaround of signed orders,” said Conner Nelson, director of operations at CSI Pharmacy. “This venture represents a significant step for our company as we continue to explore new strategies for advancing our position in the home infusion sector.”

According to a report by Grand View Research, Inc., the global home infusion market size is expected to reach $67.1 billion by 2030, expanding at a compound annual growth rate of 7.9% from 2022 to 2030. To accommodate the industry’s growth, Forcura’s systems help specialty pharmacies process referrals and orders faster, in addition to accepting patients whose needs align with its clinical capacity and profitability goals.

“Like other post-acute sectors, home infusion is increasingly recognizing the importance and impact of speed, accuracy and security on its margins and the quality of patient care,” said Annie Mueller Erstling, Chief Operating Officer of Forcura. “As home infusion continues to grow, partners who pivot toward a digital approach will differentiate themselves among referral sources and provide patients with the best care and experience possible.”

LINKS

• Forcura Website: https://www.forcura.com/
• CSI Website: https://csipharmacy.com/

IMDaily is brought to you by https://MyPodcast.Media
Hosted by Shawn P Neal

MyPodcast.Media produces podcasts that authentically connect brands and their target customers.

#experience #growth #pharmacy #infusiontherapy #marketing #branding #shawnpneal #mypodcastmedia #yourcustomersarelistening